Great comparison thanks @bovrilburger
Does this 4C fill me with confidence that AnteoTech can submit accurate and thorough approvals i.e. TGA or FDA. Absolutely not.
- Spelling your own product incorrectly in the first sentence of your Quarterly is a bit of a boo boo.
- Having a crack at the Government (potentially your largest future buyer) is not smart for business and shows immaturity.
- Incorrect Net Cash (8.1) is concerning and
- Estimated quarters of funding available was wrong by x4 (8.5).
Come on Derek and Jack. Is is absolutely amateur. No question.
Great comparison thanks @bovrilburgerDoes this 4C fill me with...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.3¢ | 2.1¢ | $259.2K | 11.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 7214585 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 774070 | 4 |
View Market Depth
| Last trade - 15.14pm 30/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |